Safety, Pharmacokinetics, and Pharmacodynamics of ARC1779 in Healthy Volunteers
Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to establish the overall safety and tolerability of ARC1779 in
healthy volunteers, and to characterize its pharmacokinetic and pharmacodynamic profile with
respect to parameters of platelet function and von Willebrand Factor activity.